Sulprostone, a synthetic prostaglandin with potent uterotonic action, has been shown to have a low complication rate in a large series. We present a case in which a bolus intravenous injection of sulprostone 30 μg was administered to treat postpartum haemorrhage during caesarean section. The 38-year-old patient with no previous cardiac or smoking history developed complete heart block, ventricular fibrillation and subsequent asystole. Cardiopulmonary resuscitation was successful after 45 minutes. Post resuscitation there was no myocardial infarction and she had complete neurological recovery. We postulate that the bolus of sulprostone resulted in possible coronary spasm that resulted in cardiac arrest.
UlmannA., SilvestreL., ChemanaL.Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16369 women.Acta Obstet Gynaecol Scand1992; 71: 281–283.
2.
AvrechO.M., BulovskyI., GolanA.Mefepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.Fertil Steril1991; 56: 385–391.
PeatfieldR.C., SillettR.W., TaylorD., McNicholM.W.Survival after cardiac arrest in hospital.Lancet1977; i: 1233–1235.
5.
WoogR.H., TorzilloP.J.Inhospital cardiopulmonary resuscitation: prospective survey of management and outcome.Anaesth Intensive Care1987; 15: 193–198.
6.
LarssonB., JonassonA., CarlstromK.Sulprostone, a synthetic PGE2 analogue in first trimester abortion. Clinical efficacy and influence on serum progesterone of different single doses.Gynaecol Obstet Invest1990; 29: 10–12.
7.
World Health Organization.Menstrual regulation by intramuscular injections of 16-phenoxy-tetranor PGE2 methyl-sulfonylamide (sulprostone). A multi centre study.Br J Obstet Gynaecol1989; 96: 207–212.
8.
HenshawR.C., CooperK., el-RefaeyH.Medical management of miscarriage: non surgical uterine evacuation of incomplete and inevitable spontaneous abortion.Br Med J1993; 306: 894–895.
9.
LaudanskiT., LitorowiczA., AkerlundM.Induction of labor in intrauterine fetal death with 16-phenoxy-prostaglandin-E2-methysulfonylamide (sulprostone)-effects on uterine contractility, coagulation and kallikrein-kinin systems.Gynecol Obstet Invest1990; 29: 269–272.
10.
PoeschmannR.P., DoesburgW.H., EskesT.K.A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour.Br J Obstet Gynaecol1991; 98: 528–530.
11.
Van SelmM., KanhaiH.H., KeirseMj.Preventing the recurrence of atonic postpartum haemorrhage: a double blind trial.Acta Obstet Gynaecol Scand1995; 74: 270–274.
12.
GoffinetF., HaddadB., CarbonneB.Practical use of sulprostone in the treatment of hemorrhages during delivery.J Gynecol Obstet Biol Reprod Paris1995; 24: 209–216.
13.
ScheringA.G.Nalador®, prostaglandin E2 derivative product information. Fliers E, Duren DR, Van Zweiten A. A prostaglandin analogue as a possible cause of myocardial infarction in a young woman.Br Med J1991; 302: 416–417.
14.
Anonymous. A death associated with mifepristone/sulprostone.Lancet1991; 337: 969–970.
15.
BagniE, BompaniB, MagnavacchiP. Angina prolungatadopo somministrazione di un derivato sintico di PGE2.G-Ital-Cardiol1993; 23: 719–721.
16.
BeamishR.E., DasP.K., KarmazynM.Prostaglandins and heart disease.Can J Cardiol1985; 1: 66–74.
17.
EversA.S., MurphreeS., SaffitzJ.E.Effects of endogenously produced leukotrienes, thromboxane and prostaglandins on coronary vascular resistance in rabbit myocardial infarction.J Clin Invest1985; 75: 992–999.
18.
NeriS., GensiniG.F., AbbateR.Physiologic role of coronary PG12 and PGE2 in modulating vascular response to sympathetic stimulation.Am Heart J1990; 119: 848–854.
